• Dr. Archana Kumbar
• DR. Ashok Kumar B N MD(Ayu)
• Dr. Ravindra Angadi MD(Ayu), PhD
• Dr. Radhika Ranjan Geethesh P MD(Ayu)
• Dr. Sushmitha V S MD(Ayu)

Cancer is a large group of diseases characterized by the growth of abnormal cells beyond their usual boundaries which can affect almost any part of the body. The most common cause of cancer death is due to breast, lung and liver cancer. Haridradi Lepa was explained in Bhavaprakasha Nighantu in the context of granthi-arbuda chikitsa. Cell culture is the best model in testing the drugs for its anticancer activity. Hence an In vitro anticancer activity of Haridradi Lepa was screened for A549 (Ca lung), HepG2 (Ca liver) and MDAMB 231 (Ca breast) cell lines. The screening was also done to evaluate the cytotoxicity effect on normal human cell lines, HEK293. It showed more cytotoxicity effect in normal cell line when compared to cancer cells.

Haridradi Lepa; Arbuda; Cancer; Cell lines;

"Experimental Evaluation of Haridradi Lepa in Human Cancer Cell Lines", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.8, Issue 9, page no.b445-b452, September-2021, Available :http://www.jetir.org/papers/JETIR2109154.pdf

"Experimental Evaluation of Haridradi Lepa in Human Cancer Cell Lines", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.8, Issue 9, page no. ppb445-b452, September-2021, Available at : http://www.jetir.org/papers/JETIR2109154.pdf